Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Sars-Cov-2-Related and Covid-19 Vaccine-Induced Thromboembolic Events: A Comparative Review Publisher Pubmed



Afshar ZM1 ; Barary M2, 3 ; Babazadeh A4 ; Hosseinzadeh R2 ; Alijanpour A5 ; Miri SR6 ; Sio TT7 ; Sullman MJM8, 9 ; Carsonchahhoud K10 ; Langer F11 ; Ebrahimpour S4
Authors

Source: Reviews in Medical Virology Published:2022


Abstract

Since the start of the pandemic, thrombotic events have been a well-known and severe complication associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Nevertheless, the initiation of vaccination programs brought another rare yet highly fatal thrombotic event, vaccine-induced immune thrombotic thrombocytopaenia, which has caused extensive debate regarding the safety of vaccines. This review defines the thromboembolic events following infection and vaccination, identifies their risk factors, describes their pathophysiology, and discusses their management, treatment, and prevention. © 2022 John Wiley & Sons Ltd.
Related Docs
View other Related Docs
1. Anticoagulant Therapy in Covid-19: A Narrative Review, Clinical and Translational Science (2023)
2. Chadox1 Ncov-19 Vaccine and Thrombosis With Thrombocytopenia Syndrome Among Adults: A Systematic Review, Advanced Pharmaceutical Bulletin (2023)
3. Acute Ischemic Stroke and Vaccine-Induced Immune Thrombotic Thrombocytopenia Post Covid-19 Vaccination; a Systematic Review, Journal of the Neurological Sciences (2022)
Experts (# of related papers)
View all Related Experts
Azita Hajhossein Talasaz (5)
Hossein Khalili (3)
Other Related Docs
4. Coagulopathy: Another Side Effect of Coronavirus Infection, Journal of Cardiovascular and Thoracic Research (2021)
5. Post-Discharge Thromboembolic Events in Covid-19 Patients: A Review on the Necessity for Prophylaxis, Clinical and Applied Thrombosis/Hemostasis (2023)
6. Recent Randomized Trials of Antithrombotic Therapy for Patients With Covid-19: Jacc State-Of-The-Art Review, Journal of the American College of Cardiology (2021)
7. Thrombotic Thrombocytopenia After Sinopharm Bbibp-Corv Covid-19 Vaccination, Research and Practice in Thrombosis and Haemostasis (2022)
8. Autoimmunity Roots of the Thrombotic Events After Covid-19 Vaccination, Autoimmunity Reviews (2021)
9. Sars-Cov-2 and Acute Cerebrovascular Events: An Overview, Journal of Clinical Medicine (2021)
10. A Review of the Potential Neurological Adverse Events of Covid-19 Vaccines, Acta Neurologica Belgica (2023)
11. Do We Miss Rare Adverse Events Induced by Covid-19 Vaccination?, Frontiers in Medicine (2022)
12. Intermediate Versus Standard-Dose Prophylactic Anticoagulation and Statin Therapy Versus Placebo in Critically-Ill Patients With Covid-19: Rationale and Design of the Inspiration/Inspiration-S Studies, Thrombosis Research (2020)
13. Intermediate-Dose Versus Standard-Dose Prophylactic Anticoagulation in Patients With Covid-19 Admitted to the Intensive Care Unit: 90-Day Results From the Inspiration Randomized Trial, Thrombosis and Haemostasis (2021)
14. Comprehensive Review of Cardiovascular Complications of Coronavirus Disease 2019 and Beneficial Treatments, Cardiology in Review (2022)
15. Covid-19 Vaccines and Thrombosis—Roadblock or Dead-End Street?, Biomolecules (2021)
16. Knowledge Gaps for Prophylactic Use of Antithrombotic Agents in Patients With Covid-19: Insights Into New Sars-Cov-2 Variants, Vaccination Status, and Emerging Oral Antivirals, Thrombosis and Haemostasis (2023)
17. Pathogenesis, Clinical Manifestations and Complications of Coronavirus Disease 2019 (Covid-19), Future Microbiology (2020)
18. Venous Thromboembolism in Viral Diseases: A Comprehensive Literature Review, Health Science Reports (2023)
19. Breakthrough Sars-Cov-2 Infections After Vaccination: A Critical Review, Human Vaccines and Immunotherapeutics (2022)
20. Cardiovascular Complications of Covid-19: Pharmacotherapy Perspective, Cardiovascular Drugs and Therapy (2021)